UnderstandingGLP-1 MedicationsThe Science Behind the Breakthrough
GLP-1 receptor agonists are among the most researched medications in modern medicine. This guide explains what they are, how they work, and what the published clinical data shows — so you can have informed conversations with your healthcare provider.
What Is GLP-1?A Natural Hormone
GLP-1 stands for Glucagon-Like Peptide-1. It is a hormone that your body naturally produces in the small intestine after you eat. GLP-1 plays a central role in how your body processes food and regulates energy.
Your Body's Natural GLP-1
When you eat, specialized cells in your intestine (called L-cells) release GLP-1 into your bloodstream. This natural hormone sends signals to your brain that help you feel satisfied after eating. It also stimulates insulin release and slows down the speed at which food leaves your stomach.
Natural GLP-1 is broken down quickly in the body — typically within minutes — by an enzyme called DPP-4. This rapid breakdown is one reason why GLP-1 medications were developed: to provide a longer-lasting version of this beneficial hormone.
GLP-1 Receptor Agonist Medications
GLP-1 receptor agonists are medications that mimic the action of natural GLP-1 but are engineered to last much longer in the body. While natural GLP-1 breaks down in minutes, these medications can remain active for days — which is why most are taken as a once-weekly injection.
The first GLP-1 receptor agonist, exenatide (Byetta), was FDA-approved in 2005 for type 2 diabetes. Since then, the class has expanded significantly. In 2021, semaglutide (Wegovy) became the first GLP-1 approved specifically for chronic weight management in adults, marking a major shift in how obesity is treated as a medical condition.
A Brief History of GLP-1 Medications
Exenatide (Byetta) becomes the first FDA-approved GLP-1 receptor agonist for type 2 diabetes
Liraglutide (Victoza) approved for type 2 diabetes — the first once-daily GLP-1
Liraglutide (Saxenda) approved for chronic weight management
Semaglutide (Ozempic) approved for type 2 diabetes
Oral semaglutide (Rybelsus) approved — the first oral GLP-1 medication
Semaglutide (Wegovy) approved for chronic weight management
Tirzepatide (Mounjaro) approved for type 2 diabetes — a dual GIP/GLP-1 agonist
Tirzepatide (Zepbound) approved for chronic weight management
How GLP-1 MedicationsWork in the Body
GLP-1 receptor agonists work through several interconnected mechanisms. Here is a simplified overview of the primary ways these medications affect the body.
Appetite Regulation
GLP-1 medications act on receptors in the hypothalamus — the brain region that controls hunger and satiety. By activating these receptors, the medications help reduce appetite and decrease what researchers call “food noise” — the persistent thoughts about food that many people experience.
Clinical trials have documented significant reductions in caloric intake among participants taking GLP-1 medications.
Slowed Gastric Emptying
GLP-1 medications slow the rate at which food moves from the stomach into the small intestine. This process, called delayed gastric emptying, means food stays in the stomach longer — helping you feel full for an extended period after eating.
This mechanism contributes to both reduced food intake and more stable blood sugar levels after meals.
Blood Sugar Control
GLP-1 medications stimulate insulin secretion in a glucose-dependent manner — meaning they help your pancreas release insulin when blood sugar is elevated, but not when it is already low. This reduces the risk of hypoglycemia compared to some other diabetes medications.
This is the primary reason GLP-1 receptor agonists were originally developed for type 2 diabetes management.
Note: This is a simplified overview of how these medications work. The full mechanism of action involves additional pathways, including effects on glucagon secretion and potential cardiovascular benefits. Your healthcare provider can explain the specific mechanism most relevant to your treatment.
FDA-ApprovedGLP-1 Medications
Several GLP-1 receptor agonists have been approved by the FDA for different indications. Approved indications and formulations may vary — always consult your prescribing healthcare provider.
Semaglutide Medications
Ozempic
2017Wegovy
2021Rybelsus
2019Tirzepatide Medications (Dual GIP/GLP-1)
Mounjaro
2022Zepbound
2023Note: Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it targets both the GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors. This dual mechanism distinguishes it from pure GLP-1 receptor agonists.
Other Notable GLP-1 Receptor Agonists
Saxenda / Victoza
Trulicity
What the ClinicalTrials Show
GLP-1 medications have been studied in some of the largest clinical trials in obesity and diabetes medicine. Here is what the published data shows.
Semaglutide (Wegovy)
average body weight loss
Trial: STEP 1 (Semaglutide Treatment Effect in People with obesity)
Participants: 1,961 adults
Duration: 68 weeks
Placebo: 2.4% average loss
Published: New England Journal of Medicine (2021)
Tirzepatide (Zepbound)
average body weight loss (highest dose)
Trial: SURMOUNT-1
Participants: 2,539 adults
Duration: 72 weeks
Placebo: 3.1% average loss
Published: New England Journal of Medicine (2022)
Important: Individual results vary significantly. These are averages from clinical trial populations with specific inclusion criteria. Your results may differ. Clinical trials also included lifestyle counseling and calorie reduction goals. See our detailed weight loss results page for more comprehensive data.
How Dose AI HelpsGLP-1 Users
Dose AI is designed specifically for people on GLP-1 medications. Track your progress, nutrition, and medication — all in one place. Dose AI is a tracking tool, not a medical device.
Medication Tracking
Log injections, track injection site rotation, and set reminders so you never miss a dose. See your complete medication history at a glance.
AI-Powered Nutrition
Scan food with your camera and get instant nutrition breakdowns. Track protein, calories, and macros — especially important for preserving muscle on GLP-1 medications.
Weight Progress
Track weight trends over time with visual charts. See your trajectory, identify patterns, and share progress data with your healthcare provider.
Side Effect Monitoring
Log symptoms and side effects to understand patterns. This data can be valuable when discussing your treatment with your healthcare provider.
Injection Site Rotation
Automatically track where you last injected and get guidance on proper rotation. Helps prevent injection site reactions and ensures consistent absorption.
Smart Insights
Get personalized insights based on your tracking data. Understand trends in your weight, nutrition, and symptoms over time to stay informed about your progress.
Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making any decisions about your health or medications.
Frequently AskedQuestions
Common questions about GLP-1 medications answered with factual, research-based information.
Have More Questions?What does GLP-1 stand for?
GLP-1 stands for Glucagon-Like Peptide-1. It is a naturally occurring hormone produced in the gut that plays a key role in regulating appetite, blood sugar levels, and digestion. GLP-1 receptor agonist medications mimic the action of this natural hormone but are engineered to last much longer in the body.
Are GLP-1 medications safe?
GLP-1 medications have been FDA-approved after extensive clinical trials involving tens of thousands of participants. Like all medications, they have potential side effects — most commonly gastrointestinal effects such as nausea, vomiting, and diarrhea, which typically decrease over time. The safety profile varies by specific medication and individual health factors. Always discuss risks and benefits with your healthcare provider before starting any medication.
How are GLP-1 medications taken?
Most GLP-1 medications are administered as weekly subcutaneous injections using a pre-filled pen device. Some oral formulations exist, such as Rybelsus (oral semaglutide), which is taken as a daily tablet on an empty stomach. Your healthcare provider will determine the most appropriate form and administration schedule based on your individual needs and treatment goals.
Do you need a prescription for GLP-1 medications?
Yes. All GLP-1 medications currently available require a prescription from a licensed healthcare provider. They are not available over the counter. A healthcare provider will evaluate your medical history, current health status, and treatment goals to determine whether a GLP-1 medication is appropriate for you.
How long do you take GLP-1 medications?
Treatment duration varies and should be determined by your healthcare provider based on your individual health goals and response to treatment. Some patients may take GLP-1 medications for a defined period, while others may benefit from long-term use. Research on discontinuation effects is ongoing, and the decision to stop should always be made in consultation with your doctor.
Can Dose AI replace my doctor?
No. Dose AI is a tracking and information tool designed to help you monitor your GLP-1 journey — including medication timing, nutrition, weight trends, and symptoms. It is not a medical device, does not provide medical advice, and is not a substitute for professional medical care. Always consult your healthcare provider for decisions about your medications and treatment plan.
What is the difference between GLP-1 agonists for diabetes and weight loss?
GLP-1 receptor agonists were originally developed for type 2 diabetes management. Some medications have since been approved at different doses specifically for chronic weight management. For example, semaglutide is available as Ozempic (for type 2 diabetes) and Wegovy (for weight management). The active ingredient is the same, but the approved indications, dosing schedules, and target patient populations may differ.
What are the most common side effects of GLP-1 medications?
The most commonly reported side effects in clinical trials include nausea, vomiting, diarrhea, constipation, and abdominal pain. These gastrointestinal effects are typically most pronounced during the initial dose-titration period and often decrease over time as the body adjusts. Less common but more serious side effects have also been reported. Your healthcare provider can discuss the full range of potential side effects specific to your medication.
Track Your GLP-1 Journeywith Dose AI
Whether you're just starting a GLP-1 medication or months into your journey, Dose AI helps you track what matters — nutrition, medication, weight, and symptoms — all in one place.
Free download · iOS · Premium features available
Dose AI is a tracking and information tool, not a medical device. Always consult your healthcare provider for medical advice about your GLP-1 medication.